Editor's choice

Special Feature

ESMO 2016 Immunotherapy for GU cancers: latest advances and future approaches The rapidly evolving field of immunotherapy in the treatment of genitourinary (GU) cancers was covered in a satellite symposium, sponsored by F. Hoffmann-La Roche, and held at the European Society for Medical Oncology (...

Latest Articles


Editor's choice

Axel Merseburger, Shaji Kumar, Sharlene Gill, Ahmad Awada, Paolo Ascierto and Maurice Perol discuss their experiences with the European Oncology...

Latest Videos

As well as our peer-reviewed journals, we also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.


touchONCOLOGY provides a selection of resources to inform physicians, clinicians and related HCPs about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Durvalumab: first immunotherapy to be approved for stage III non-small cell lung cancer Katrina Mountfort, Medical Writer, Touch Medical Media, Goring-on-Thames, UK
Meeting Preview
EANM FOCUS 1: The First Focus Meeting of the European Association of Nuclear Medicine Katrina Mountfort, Medical Writer, Touch Medical Media, Goring-on-Thames, UK
First-line Treatment Options for Renal Cell Carcinoma Ulka Vaishampayan, Oncology Multidisciplinary Team Chair and Associate Professor, Karmanos Cancer Institute, Wayne State University, Detroit, MI, US
ASCO 2017 Insight – High Dose Interleukin 2 Katrina Mountfort, Touch Medical Media, Reading, UK
MONALEESA-2 secondary analyses support safety and efficacy for ribociclib/letrozole for breast cancer Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, UK